Navigation Links
CareFusion Recommends Rejection of Mini-Tender Offer by TRC Capital
Date:12/17/2009

SAN DIEGO, Dec. 17 /PRNewswire-FirstCall/ -- CareFusion Corporation (NYSE: CFN) announced today that it has been notified of an unsolicited mini-tender offer by TRC Capital Corporation (TRC) to purchase up to four million shares of CareFusion common stock, representing approximately 1.8 percent of the shares of common stock outstanding. TRC's offer price of $23.50 per share is 4.62 percent below the share closing price of CareFusion common stock on Dec. 14, 2009, the last full trading day prior to the offer. CareFusion also noted that the offer is subject to a number of conditions, including the right to terminate in the event of a decrease in the market price of CareFusion shares. TRC has made numerous similar, unsolicited mini-tender offers for shares of other companies in the past.

CareFusion strongly recommends against shareholders tendering their shares in response to TRC's unsolicited mini-tender offer. Mini-tender offers, such as this one, avoid many of the investor protections afforded to larger tender offers, including the filing of disclosure and other tender offer documents with the Securities and Exchange Commission (SEC) and other procedures mandated by U.S. securities laws. CareFusion is in no way associated with TRC, its mini-tender offer or the offer documentation.

The SEC has issued an investor advisory regarding mini-tender offers, noting that in making the offers at below-market prices "bidders are hoping that they will catch investors off guard if the investors do not compare the offer price to the current market price." Investors are urged to consult with their brokers or financial advisors on such matters. The SEC advisory may be found on the SEC web site, at www.sec.gov/investor/pubs/minitend.htm.

CareFusion urges shareholders to obtain current market quotations for their shares of common stock, to consult with their financial advisors and to exercise caution with respect to this offer. The company advises shareholders who already have tendered that they may withdraw their common shares by providing the written notice described in the TRC offering documents prior to the expiration of the offer, currently scheduled for 12:01 a.m. EST on Thursday, Jan. 14, 2010.

About CareFusion Corporation

CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® IV pumps, Pyxis® automated dispensing and patient identification systems, AVEA® and Pulmonetic Systems ventilators, ChloraPrep® for infection prevention, MedMined(TM) services for infection surveillance, NeuroCare neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 15,000 people across its global operations. More information may be found at www.carefusion.com.

SOURCE CareFusion Corporation


'/>"/>
SOURCE CareFusion Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Quantros Acquires MediQual(TM) From CareFusion Corporation
2. New Medical Technology Company CareFusion Spins Off From Cardinal Health, Begins Trading on NYSE
3. Cardinal Health Completes Spinoff of CareFusion Corp.
4. CareFusion Corp to be Included in S&P 500 Index
5. CareFusion Issues Update Regarding Previously Disclosed June 12, 2009 Recall of the Alaris(R) System
6. CareFusion Form 10 Registration Statement Declared Effective
7. CareFusion Expands Pyxis(R) Perioperative Solutions Offering
8. CareFusion Prices $1.4 Billion of Senior Notes
9. Cardinal Health Board of Directors Approves CareFusion Spinoff
10. CareFusion to Resume Shipping Alaris(R) Infusion Products
11. CareFusion Corporation Launches International Jazz Festival Series
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... Restoration, has recently contributed a medical article to the newly revamped Cosmetic ... Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Leading pediatric ... peers in Washington, D.C., for the 49th Congress of the International Society of ... Vice President of the Center for Cancer and Blood Disorders at Children’s ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United States, ... In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the ... have extremely low property-tax rates, which contributes to the relatively lower cost of ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/22/2017)... DIEGO , Sept. 22, 2017 AVACEN ... medical device is now successfully helping those with the ... Fibromyalgia diagnosed Amanda in Essex, ... dressed and washing my hair, experiencing no sleep at ... in painful spasm… I cannot recommend [the AVACEN 100] ...
(Date:9/19/2017)... ZirMed Inc ., a recognized leader in cloud-based revenue cycle ... ranked #1 by its users for the seventh consecutive year ... ZirMed was recognized as the top-ranked end-to-end revenue cycle management ... 200 beds and holds one of the longest #1 ranking ... ...
Breaking Medicine Technology: